Richard Harry Weisler
Adjunct Professor in the Department of Psychiatry and Behavioral Sciences
Current Appointments & Affiliations
- Adjunct Professor in the Department of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Adult Psychiatry & Psychology, Psychiatry & Behavioral Sciences 2017
Contact Information
- Box 3862 Med Ctr, Durham, NC 27710
- Clin & Res Labs, Durham, NC 27710
-
rweisler@aol.com
(919) 872-5900
- Background
-
Education, Training, & Certifications
- M.D., University of North Carolina - Chapel Hill 1976
-
Previous Appointments & Affiliations
- Adjunct Associate Professor of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Adult Psychiatry & Psychology, Psychiatry & Behavioral Sciences 2013 - 2017
- Adjunct Associate Professor of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Medical Psychology, Psychiatry & Behavioral Sciences 2006 - 2013
- Adjunct Assistant Professor of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Clinical Science Departments 2002 - 2006
- Adjunct Associate in Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Clinical Science Departments 1994 - 2002
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Weisler, Richard H., Michael Greenbaum, Valerie Arnold, Ming Yu, Brian Yan, Margo Jaffee, and Brigitte Robertson. “Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study.” Cns Drugs 31, no. 8 (August 2017): 685–97. https://doi.org/10.1007/s40263-017-0455-7.Full Text Link to Item
-
Weisler, Richard H., Ai Ota, Kana Tsuneyoshi, Pamela Perry, Emmanuelle Weiller, Ross A. Baker, and David V. Sheehan. “Brexpiprazole as an adjunctive treatment in young adults with major depressive disorder who are in a school or work environment.” J Affect Disord 204 (November 1, 2016): 40–47. https://doi.org/10.1016/j.jad.2016.06.001.Full Text Link to Item
-
Weisler, Richard H., Stuart A. Montgomery, Willie R. Earley, Johan Szamosi, and Arthur Lazarus. “Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies.” Int Clin Psychopharmacol 27, no. 1 (January 2012): 27–39. https://doi.org/10.1097/YIC.0b013e32834d6f91.Full Text Link to Item
-
Weisler, Richard H., Joseph R. Calabrese, Charles L. Bowden, John A. Ascher, Joseph DeVeaugh-Geiss, and Gary Evoniuk. “Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence.” J Affect Disord 108, no. 1–2 (May 2008): 1–9. https://doi.org/10.1016/j.jad.2007.09.012.Full Text Link to Item
-
Weisler, Richard H. “Emerging drugs for attention-deficit/hyperactivity disorder.” Expert Opin Emerg Drugs 12, no. 3 (September 2007): 423–34. https://doi.org/10.1517/14728214.12.3.423.Full Text Link to Item
-
Weisler, Richard H. “Review of long-acting stimulants in the treatment of attention deficit hyperactivity disorder.” Expert Opin Pharmacother 8, no. 6 (April 2007): 745–58. https://doi.org/10.1517/14656566.8.6.745.Full Text Link to Item
-
Weisler, Richard H., Andrew J. Cutler, James C. Ballenger, Robert M. Post, and Terence A. Ketter. “The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials.” Cns Spectr 11, no. 10 (October 2006): 788–99. https://doi.org/10.1017/s1092852900014917.Full Text Link to Item
-
Weisler, Richard H., James G. Barbee, and Mark H. Townsend. “Mental health and recovery in the Gulf Coast after Hurricanes Katrina and Rita.” Jama 296, no. 5 (August 2, 2006): 585–88. https://doi.org/10.1001/jama.296.5.585.Full Text Link to Item
-
Weisler, Richard H., Joseph Biederman, Thomas J. Spencer, Timothy E. Wilens, Stephen V. Faraone, Allan K. Chrisman, Stephanie C. Read, and Simon J. Tulloch. “Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial.” Cns Spectr 11, no. 8 (August 2006): 625–39. https://doi.org/10.1017/s1092852900013687.Full Text Link to Item
-
Weisler, Richard H. “Carbamazepine extended-release capsules in bipolar disorder.” Neuropsychiatr Dis Treat 2, no. 1 (March 2006): 3–11.Link to Item
-
Weisler, Richard H., Robert Hirschfeld, Andrew J. Cutler, Thomas Gazda, Terence A. Ketter, Paul E. Keck, Alan Swann, Amir Kalali, and Amir SPD417 Study Group. “Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.” Cns Drugs 20, no. 3 (2006): 219–31. https://doi.org/10.2165/00023210-200620030-00004.Full Text Link to Item
-
Weisler, Richard H., Joseph Biederman, Thomas J. Spencer, and Timothy E. Wilens. “Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD.” Cns Spectr 10, no. 12 Suppl 20 (December 2005): 35–43. https://doi.org/10.1017/s109285290000242x.Full Text Link to Item
-
Weisler, Richard H. “Carbamazepine extended-release capsules: a new treatment option for bipolar I disorder.” Expert Rev Neurother 5, no. 5 (September 2005): 587–95. https://doi.org/10.1586/14737175.5.5.587.Full Text Link to Item
-
Weisler, Richard H. “Safety, efficacy and extended duration of action of mixed amphetamine salts extended-release capsules for the treatment of ADHD.” Expert Opin Pharmacother 6, no. 6 (June 2005): 1003–18. https://doi.org/10.1517/14656566.6.6.1003.Full Text Link to Item
-
Weisler, Richard H., Paul E. Keck, Alan C. Swann, Andrew J. Cutler, Terence A. Ketter, Amir H. Kalali, and Amir H. SPD417 Study Group. “Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.” J Clin Psychiatry 66, no. 3 (March 2005): 323–30. https://doi.org/10.4088/jcp.v66n0308.Full Text Link to Item
-
Weisler, Richard H., Amir H. Kalali, Terence A. Ketter, and Terence A. SPD417 Study Group. “A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.” J Clin Psychiatry 65, no. 4 (April 2004): 478–84. https://doi.org/10.4088/jcp.v65n0405.Full Text Link to Item
-
-
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.